You may not be able to see nasal polyps, but that doesn’t mean you can’t sense their constant presence. In fact, more than half of people who have the condition say that reducing or eliminating their ...

SAN DIEGO -- Tezepelumab (Tezspire) reduced nasal polyps and symptoms in severe chronic rhinosinusitis while also decreasing need for further treatments, the WAYPOINT trial showed. The monoclonal ...

For severe chronic rhinosinusitis with nasal polyps, the novel monoclonal antibody stapokibart reduced symptoms and polyp size atop treatment with a daily intranasal corticosteroid. The polyp size ...

Tezepelumab (Tezspire) has shown significant clinical benefits in adults with severe chronic rhinosinusitis with nasal polyps (CRSwNP), including marked reductions in nasal congestion and polyp size ...

Addition of the monoclonal antibody stapokibart significantly improved nasal polyps and nasal congestion in adults with uncontrolled chronic rhinosinusitis with nasal polyps, based on new data from ...

Nasal cancer is rare, but it can be aggressive. Early diagnosis and treatment can often help keep it from spreading. Share on Pinterest Getty Images/FG Trade Nasal cancer, also known as nasal cavity ...